|
|
 |
 |
| |
 Printable version |
Clinical significance of an intense, pulsed light source on leg telangiectasias of up to 1 mm diameter |
European Journal of Dermatology. Volume 7, Number 1, 38-42, January - February 1997, Thérapie
|
 Free Article
|
Author(s) : C.A. Schroeter, D. Wilder, T. Reineke, W. Thürlimann, C. Raulin,
H.A.M. Neumann |
Summary : Telangiectasias on the legs are difficult to treat in contrast to those on the face. Sclerotherapy is widely used but often results in hyperpigmentation. Procedures such as argon, pulsed dye and copper vapor laser treatment may lead to scarring. Forty female patients with blue and red telangiectasias on the legs were treated with a new, intense light source, the PhotoDerm® VL, developed by Energy Systems Corporation Inc (ESC), Boston, USA. The diameter of the vessels was between 0.2 mm and 1 mm.
The average age of the patients was 41.7 years, the youngest was 24 years and the oldest 72 years. Patients were treated within the spectrum of 515 nm to 590 nm with varying pulse durations. Energy varied from 20 to 70 J/cm2. Reticular and feeding veins were treated first. Immediate clearing was achieved in 73.6% of the patients and in 84.3% of the patients after four weeks. Concerning the immediate response, 82.0% clearing was seen in the group with veins of up to 0.2 mm diameter, 78.9% was seen in the group from 0.2 up to 0.5 mm and 59.7% was seen in the group from 0.5 to 1 mm. After 1 month, clearing was seen in 92.1% in the first group, 80.0% in the second group and 81,0% in the third group of patients. Cosmetic results were excellent, neither telangiectatic matting nor scarring was seen. There was no recurrence in the follow-up period of 1 year. Our results show that treatment of telangiectatic veins of the leg with the PhotoDerm® VL is an effective treatment with minimal damage to the skin. |
Keywords : |
|
